Gathered.com
  • Vision
  • Difference
  • Contact Us
  • Opportunities
  • Blog
  • Offerings
Select Page

Optimizing and Individualizing CIDP Treatment

by Michael Fenimore | Dec 3, 2025 | Neurology

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a progressive immune-mediated disorder of the peripheral nerves attributed to demyelination and impairment of signal conduction in motor and/or sensory nerves.

Navigating Real-World Issues in the Management of Eosinophilic Esophagitis

by Michael Fenimore | Dec 3, 2025 | Allergy and Immunology, Pediatrics, Pharmacy

This curriculum provides practical guidance on the diagnosis and management of eosinophilic esophagitis (EoE), a chronic, immune-mediated disease of the esophagus with rising prevalence. Learners will engage with current diagnostic algorithms, examine treatment...

The Evolving Landscape of GEP-NETs – From Precise Staging to Novel Treatments and Coordinated Care

by Michael Fenimore | Dec 3, 2025 | Endocrinology, Hematology-Oncology, Oncology

This program is designed to provide you with the latest strategies for accurately diagnosing, staging, and treating GEP-NETs by integrating pathological grading with advanced imaging and novel systemic therapies. This activity emphasizes a collaborative approach,...

Postpartum Depression in Practice – From Universal Screening to Individualized Treatment Within OB/GYN Settings

by Michael Fenimore | Dec 3, 2025 | Gynecology, Obstetrics/Gynecology

Postpartum depression (PPD) affects up to one in seven women and is a leading cause of maternal morbidity, with profound implications for both the patient and her family. Untreated PPD can lead to chronic depression, impaired maternal-infant bonding, strained partner...

Obesity Care Reimagined: Simulations for Real Impact

by Stefan Ravello | Sep 16, 2025 | Cardiology, Endocrinology, Obstetrics/Gynecology, Weight Management

Obesity currently affects more than 2 in 5 adults in the United States and demonstrates significant associations with cardiovascular disease, type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH),...
« Older Entries
Next Entries »
Copyright © 2026 HealthCourse Inc. All rights reserved.
Privacy Policy | Terms of Service | Cookie Policy | |